138 related articles for article (PubMed ID: 6221691)
1. Cefoperazone pharmacokinetics in normal subjects and patients with cirrhosis.
Boscia JA; Korzeniowski OM; Snepar R; Kobasa WD; Levison ME; Kaye D
Antimicrob Agents Chemother; 1983 Mar; 23(3):385-9. PubMed ID: 6221691
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of cefoperazone in patients with normal and impaired hepatic and renal function.
Greenfield RA; Gerber AU; Craig WA
Rev Infect Dis; 1983; 5 Suppl 1():S127-36. PubMed ID: 6221382
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of cefoperazone: a review.
Craig WA; Gerber AU
Drugs; 1981; 22 Suppl 1():35-45. PubMed ID: 6456890
[TBL] [Abstract][Full Text] [Related]
4. A review and summary of the pharmacokinetics of cefoperazone: a new, extended-spectrum beta-lactam antibiotic.
Neu HC
Ther Drug Monit; 1981; 3(2):121-8. PubMed ID: 6455787
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of cefoperazone in patients with neoplastic disease.
Maksymiuk AW; LeBlanc BM; Brown NS; Ho DH; Bodey GP
Antimicrob Agents Chemother; 1981 Jun; 19(6):1037-41. PubMed ID: 6455966
[TBL] [Abstract][Full Text] [Related]
6. Comparative pharmacokinetics of cefoperazone and cefamandole.
Srinivasan S; Francke EL; Neu HC
Antimicrob Agents Chemother; 1981 Feb; 19(2):298-301. PubMed ID: 6214988
[TBL] [Abstract][Full Text] [Related]
7. Comparative pharmacokinetics of moxalactam, cefoperazone, and cefotaxime in normal volunteers.
Standiford HC; Drusano GL; McNamee WB; Tatem B; Ryan PA; Schimpff SC
Rev Infect Dis; 1982; 4 Suppl():S585-94. PubMed ID: 6296967
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of cefoperazone in normal volunteers and subjects with renal insufficiency.
Bolton WK; Scheld WM; Spyker DA; Sande MA
Antimicrob Agents Chemother; 1981 May; 19(5):821-5. PubMed ID: 6457558
[TBL] [Abstract][Full Text] [Related]
9. Cefoperazone pharmacokinetics in preterm infants.
Bosso JA; Chan GM; Matsen JM
Antimicrob Agents Chemother; 1983 Mar; 23(3):413-5. PubMed ID: 6221693
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacokinetic study of a cephalosporin, cefoperazone, in liver failure].
Belaieff J; Cochet B; Allaz AF; Rudhardt M; Balant L; Fabre J
Schweiz Med Wochenschr; 1981 Apr; 111(14):502-8. PubMed ID: 6453423
[TBL] [Abstract][Full Text] [Related]
11. Comparative pharmacokinetics of cefoperazone, cefotaxime, and moxalactam.
Kemmerich B; Lode H; Belmega G; Jendroschek T; Borner K; Koeppe P
Antimicrob Agents Chemother; 1983 Mar; 23(3):429-34. PubMed ID: 6303213
[TBL] [Abstract][Full Text] [Related]
12. Cefoperazone pharmacokinetics in patients with liver cirrhosis: a predictive value of the ujoviridin test.
Saudek F; Morávek J; Modr Z
Int J Clin Pharmacol Ther Toxicol; 1989 Feb; 27(2):82-7. PubMed ID: 2921099
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of moxalactam in subjects with normal and impaired renal function.
Leroy A; Humbert G; Fillastre JP
Antimicrob Agents Chemother; 1981 Jun; 19(6):965-71. PubMed ID: 6455967
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacokinetic study of a cephalosporin: cefoperazone in patients with a Kehr drain].
Farquet C; Marti MC; Balant L; Cochet B; Rudhardt M; Fabre J; Rohner A
Schweiz Med Wochenschr; 1982 Jan; 112(4):123-9. PubMed ID: 6461067
[TBL] [Abstract][Full Text] [Related]
15. Novel galactose single point method as a measure of residual liver function: example of cefoperazone kinetics in patients with liver cirrhosis.
Hu OY; Tang HS; Chang CL
J Clin Pharmacol; 1995 Mar; 35(3):250-8. PubMed ID: 7608313
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of cefoperazone (2.0 g) and sulbactam (1.0 g) coadministered to subjects with normal renal function, patients with decreased renal function, and patients with end-stage renal disease on hemodialysis.
Reitberg DP; Marble DA; Schultz RW; Whall TJ; Schentag JJ
Antimicrob Agents Chemother; 1988 Apr; 32(4):503-9. PubMed ID: 3377461
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of multiple-dose cefoperazone in hemodialysis patients.
Spyker DA; Richmond JD; Scheld WM; Bolton WK
Am J Nephrol; 1985; 5(5):355-60. PubMed ID: 4061504
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of cefoperazone in full-term and premature neonates.
Rosenfeld WN; Evans HE; Batheja R; Jhaveri RC; Vohra K; Khan AJ
Antimicrob Agents Chemother; 1983 Jun; 23(6):866-9. PubMed ID: 6225389
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of cefoperazone in normal subjects and patients with hepatosplenic schistosomiasis.
Boscia JA; Korzeniowski OM; Kobasa WD; Rocha H; Levison ME; Kaye D
J Antimicrob Chemother; 1983 Oct; 12(4):407-10. PubMed ID: 6643335
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of cefoperazone in the parturient.
Gonik B; Feldman S; Pickering LK; Doughtie CG
Antimicrob Agents Chemother; 1986 Dec; 30(6):874-6. PubMed ID: 3813513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
